Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

24 terminated/withdrawn out of 241 trials

Success Rate

83.0%

-3.5% vs industry average

Late-Stage Pipeline

8%

19 trials in Phase 3/4

Results Transparency

37%

43 of 117 completed trials have results

Key Signals

56 recruiting43 with results12 terminated12 withdrawn

Enrollment Performance

Analytics

N/A
95(53.7%)
Phase 2
31(17.5%)
Phase 1
28(15.8%)
Phase 3
12(6.8%)
Phase 4
7(4.0%)
Early Phase 1
4(2.3%)
177Total
N/A(95)
Phase 2(31)
Phase 1(28)
Phase 3(12)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (241)

Showing 20 of 241 trials
NCT00001403Recruiting

Study of Proteus Syndrome and Related Congenital Disorders

Role: collaborator

NCT06036199Not ApplicableRecruiting

Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects

Role: lead

NCT06514898Phase 1Recruiting

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

Role: collaborator

NCT00018044Recruiting

Study of Mycobacterial Infections

Role: collaborator

NCT06792500Phase 1Not Yet Recruiting

A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)

Role: collaborator

NCT03734107Not ApplicableCompleted

Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care

Role: lead

NCT07172958Phase 1Recruiting

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

Role: lead

NCT05219110Not ApplicableRecruiting

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Role: collaborator

NCT06907173Phase 3Recruiting

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

Role: collaborator

NCT04621279Recruiting

Cool Prime Comparative Effectiveness Study for Mild HIE

Role: collaborator

NCT07017816Early Phase 1Recruiting

A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.

Role: lead

NCT04612764Active Not Recruiting

Liver Disease in Urea Cycle Disorders

Role: collaborator

NCT06892158Not ApplicableRecruiting

Massage Impact on Sleep in Pediatric Oncology

Role: collaborator

NCT06065228Recruiting

Therapeutic Endpoint in Pediatric IBD Conditions

Role: lead

NCT04992299Not ApplicableCompleted

Mindfulness-Based Intervention for Depression and Insulin Resistance in Adolescents

Role: collaborator

NCT06194747Not ApplicableRecruiting

Improving Status Epilepticus Treatment Times

Role: collaborator

NCT03822442Completed

MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy Patients

Role: lead

NCT05697874Recruiting

International Rare Brain Tumor Registry

Role: lead

NCT06548022Not ApplicableCompleted

Rare Group Problem Management Plus

Role: lead

NCT04975698Phase 2Completed

HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

Role: collaborator